S100B polymorphisms are associated with age of onset of Parkinson’s disease-Reference-Cited by-同舟云学术

S100B polymorphisms are associated with age of onset of Parkinson’s disease

Published:2018-03-12 Issue:1 Volume:19 Page:
ISSN:1471-2350
Container-title:BMC Medical Genetics
language:en
Short-container-title:BMC Med Genet

Author:

Fardell Camilla^ORCID,Zettergren Anna,Ran Caroline,Carmine Belin Andrea,Ekman Agneta,Sydow Olof,Bäckman Lars,Holmberg Björn,Dizdar Nil,Söderkvist Peter,Nissbrandt Hans

Funder

Vetenskapsrådet

Swedish Brain Power

Åke Wiberg Stiftelse

LUA-ALF Foundation, Sahlgrenska University Hospital, Sweden

Karolinska Institutet Funds

Foundation For Parkinson Research in Linköping, Sweden

ParkinsonFörbundet

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/s12881-018-0547-3.pdf

Reference56 articles.

1. Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx. 2004;1:139–54.

2. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev. 2011;91:1161–218.

3. Schapira AH. Mitochondrial pathology in Parkinson’s disease. Mount Sinai J Med. 2011;78:872–81.

4. Barnum CJ, Tansey MG. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog Brain Res. 2010;184:113–32.

5. Håkansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, et al. Investigation of genes coding for inflammatory components in Parkinson's disease. Mov Disord. 2005;20:569–73.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives;IBRO Neuroscience Reports;2023-06

2. The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker;International Journal of Molecular Sciences;2023-05-31

3. Polymorphisms in the inter leukin-1 beta gene (rs16944 and rs1143627) as a risk factor for SARS-COV2 infection;1ST INTERNATIONAL CONFERENCE ON ACHIEVING THE SUSTAINABLE DEVELOPMENT GOALS;2023

4. A need to reconsider the rehabilitation protocol in patients with idiopathic Parkinson’s disease: Review analysis;Biomedicine;2022-09-12

5. Extracellular S100B inhibits A‐type voltage‐gated potassium currents and increases L‐type voltage‐gated calcium channel activity in dopaminergic neurons;Glia;2022-08-02